Veralto Corporation announced the acquisition of Montreal‑based GlobalVision for a purchase price of approximately $195 million, based on 15 times GlobalVision’s 2026 estimated adjusted EBITDA of $13 million. The deal values GlobalVision at roughly $195 million and includes cost synergies expected to be realized by the end of the second year of integration.
GlobalVision is projected to generate about $25 million in sales in 2026, with 85 % of that revenue recurring. Its standalone adjusted EBITDA margin is projected at 30 %. The acquisition is forecast to be neutral to Veralto’s adjusted earnings per share in 2026 and accretive in 2027 as synergies mature. The purchase price includes these synergies, which are expected to be achieved by the end of year two.
The transaction expands Veralto’s Esko digital workflow platform and deepens its presence in the highly regulated packaging market. “Consumer packaged goods and pharmaceutical companies are facing incredible demands to meet regulatory and brand consistency standards as they introduce new products to market quickly and accurately,” said Jennifer L. Honeycutt, President and CEO of Veralto. “Embedding GlobalVision’s core technology into Esko’s workflow solutions will help our customers get products to market faster and avoid costly errors by ensuring packaging is accurate and compliant.”
Brandon Malz, CEO of GlobalVision, added, “Joining Esko and Veralto is a natural next step — it allows us to embed that capability directly into the packaging lifecycle at global scale. Together, we see a unique opportunity to bring AI‑augmented quality and compliance deeper into our customers’ workflows and fundamentally transform how products are brought to market.”
In addition to the acquisition, Veralto disclosed a share‑repurchase program in the first quarter of 2026, buying back approximately 3.2 million shares for about $300 million, representing 1.3 % of outstanding shares. The repurchase was undertaken while shares were near a 52‑week low, underscoring management’s confidence in the company’s balance sheet and its commitment to returning value to shareholders. Veralto also announced a $750 million share‑repurchase program in November 2025 and declared a quarterly cash dividend of $0.13 per share, payable on April 30 2026.
Veralto’s broader strategy is anchored in a robust M&A pipeline. The company has completed 80 acquisitions over the past 20 years and recently announced the acquisition of In‑Situ for $435 million, expected to close in Q1 2026, to enhance its water analytics portfolio. The GlobalVision deal fits into this strategy by adding AI‑driven compliance technology to Veralto’s existing water and product quality solutions, which generate annual sales of approximately $5.5 billion and employ around 17,000 associates.
The acquisition positions Veralto to capture growth in regulated packaging markets, strengthen its recurring revenue model, and improve margin profile through AI‑enabled efficiencies. By integrating GlobalVision’s technology into Esko, Veralto can offer end‑to‑end, source‑to‑shelf packaging solutions that reduce costly errors and accelerate time‑to‑market for pharmaceutical and consumer packaged goods customers. The deal is expected to enhance Veralto’s competitive positioning and support long‑term earnings growth.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.